NCT05159986

Brief Summary

Osteoarthritis represents failed repair of joint damage resulting from stresses initiated by any joint or periarticular tissue abnormality. The rate of progression varies among persons and within a knee over time. The symptoms and signs of knee osteoarthritis include pain, stiffness, reduced joint motion, and muscle weakness. Long-term consequences can include reduced physical activity, deconditioning, impaired sleep, fatigue, depression, and disability.This reduction in activity to avoid pain (kinesiophobia) to evade the onset of pain, especially in the acute phase, limiting their compliance with effective rehabilitation strategies such as regular exercises. Physical medicine has a wide range of analgesic anti-inflammatory and muscle stimulating treatment methods. Both diadynamic and TENS currents have become the most frequently implemented electrotherapeutic methods. The impact of diadynamic currents consists of analgesic effects and specific dynamics during the formation of physiological processes in tissues. They occur during the administration of the current and lasts up to a few hours after the treatment has been terminated. One of the theories explaining the analgesic effect of diadynamic currents is the gate control theory of pain by Wall and Melzack. Recently, another theory has become very popular. It explains the analgesic effect provoked by bodies characterized as polypeptides called endorphins. Electric stimulation using diadynamic currents generates an increase in the amount of endorphins in a system. Although the analgesic impact of TENS therapy is well known, Diadynamic currents therapies have not been studied in knee osteoarthritis pain conditions. Therefore, the aim of the present study was to investigate the medium-term effects of Diadynamic currents combined with exercise on pain and disability in patients with osteoarthritis of the knee.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 16, 2021

Completed
Last Updated

December 16, 2021

Status Verified

November 1, 2021

Enrollment Period

3 months

First QC Date

November 10, 2021

Last Update Submit

December 15, 2021

Conditions

Keywords

PAINElectric Stimulation TherapyExercise Therapy

Outcome Measures

Primary Outcomes (2)

  • Change in pain intensity

    Pain intensity measured by the numeric pain rating scale (0-10) with a minimal clinically important change set at two points

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

  • Change in Disability

    Disability measured using the Lequesne questionnaire,14 which consists of 11 questions about pain, discomfort, and function. Scores range from 0 to 24 (from 'no' to 'extremely severe' dysfunction).

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

Secondary Outcomes (5)

  • Change in Medication intake (Paracetamol) for knee pain relief

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

  • Change in Mobility and balance

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

  • Change in Range of motion

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

  • Change in Muscular strength

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

  • Change in Physical activity

    outcomes were collected at baseline (before randomization) and 8 weeks from baseline by the same blinded evaluator.

Study Arms (2)

Group Diadynamic and Exercises

EXPERIMENTAL

Group Diadynamic and Exercises received Diadynamic currents associated to Exercise three times a week for 8 weeks following initial assessment (n=30, 60 knees) Diadynamic currents was performed with the following parameters: application of the two-phase current and then the long-term one. Each current was applied for 4 minutes on the medial and lateral sides of the knee.

Procedure: Group that received aplication of Diadynamic currents associated to Exercise during eight weeks with three sessions a weekOther: Group that received exercise during eight weeks with three sessions a week

Group Exercises

EXPERIMENTAL

Group Exercises received only exercises three times a week for 8 weeks following initial assessment (n=30, 60 knees).

Other: Group that received exercise during eight weeks with three sessions a week

Interventions

Diadynamic currents was performed followed by exercises (divided into Phase-1, Phase-2 and Phase-3 during eight weeks with three sessions a week).

Group Diadynamic and Exercises

The intervention was divided into Phase-1, Phase-2 and Phase-3 during eight weeks with three sessions a week. Each session lasted 45 minutes.

Group Diadynamic and ExercisesGroup Exercises

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged from 50 and 75;
  • symptomatic knee osteoarthritis for at least three months;
  • visual analogue scale12 score above 3 and
  • radiographic knee osteoarthritis (uni or bilateral) compatible with Kellgren-Lawrence13 grade two or higher.

You may not qualify if:

  • contraindication to laser application (e.g. cancer and insulin-dependent diabetes);
  • inability to perform the assessment or treatment;
  • continuous use of anti-inflammatory drugs,
  • symptomatic hip osteoarthritis
  • physiotherapeutic knee treatment within the last 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Raquel Aparecida Casarotto

São Paulo, Brazil

Location

MeSH Terms

Conditions

Osteoarthritis, KneePain

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Raquel Ap Casarotto, PhD

    USP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly allocated to a Group I (diadynamic currents associated to Exercise; n=30, 60 knees) and Group II (exercises group; n=30, 60 knees) were treated 3 times a week for 8 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2021

First Posted

December 16, 2021

Study Start

January 1, 2021

Primary Completion

April 1, 2021

Study Completion

August 1, 2021

Last Updated

December 16, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations